Home / Health / ED Drug May Raise Blindness Risk
ED Drug May Raise Blindness Risk
5 Aug
Summary
- Tadalafil use linked to a 22% higher chance of developing glaucoma.
- Study suggests a 32% increased risk of ocular hypertension with tadalafil.
- Ophthalmologists urge eye health monitoring for tadalafil patients.
An erectile dysfunction medication, tadalafil, has been associated with an increased risk of glaucoma, a condition that can lead to blindness. Scientists are advising long-term users of tadalafil to have their eye health regularly checked.
Tadalafil, also prescribed for enlarged prostate symptoms, functions by relaxing muscles and improving blood flow. However, it has been linked to various eye issues, including those affecting the optic nerve and macula.
Recent research from Taiwan suggests a potential link between tadalafil and an elevated risk of glaucoma. The study analyzed data from over 73,000 men, finding that those prescribed tadalafil showed a 22% higher likelihood of developing glaucoma and a 33% increased chance of developing primary open-angle glaucoma.
While these findings are from an observational study and do not definitively prove cause and effect, experts highlight the necessity of vigilance. Individuals with existing glaucoma, a family history of the condition, or high intraocular pressure are particularly advised to consult their doctor or optician.
Glaucoma often progresses without symptoms, making routine eye examinations crucial for early detection. The NHS notes that the condition typically affects both eyes and can develop over many years. In rare cases, glaucoma can present suddenly with severe symptoms like eye pain, redness, blurred vision, and headaches.
